Stocks and Investing
Stocks and Investing
Thu, November 11, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 10, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Upgraded (BNTX) to Strong Buy and Increased Target to $360 on, Nov 10th, 2021
Robert Burns of HC Wainwright & Co., Upgraded "BioNTech SE" (BNTX) to Strong Buy and Increased Target from $330 to $360 on, Nov 10th, 2021.
Robert has made no other calls on BNTX in the last 4 months.
There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 4 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $225 on, Tuesday, November 9th, 2021
- Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
- Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
- Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
These are the ratings of the 2 analyists that currently disagree with Robert
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
- Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
Contributing Sources